布地奈德联合硫酸特布他林雾化吸入治疗支气管哮喘的临床综合评价

Budesonide combined with Terbutaline Sulfate aerosol inhalation for treating bronchial asthma

目的分析研究布地奈德联合硫酸特布他林雾化吸入治疗支气管哮喘的临床效果及安全性。方法将76例急性发作期支气管哮喘患者按随机数字表分为观察组和对照组,每组38例。对照组进行常规方法治疗;观察组在对照组的基础上给予布地奈德联合硫酸特布他林雾化吸入治疗,两组均治疗7天,观察记录两组患者临床效果及不良反应情况。结果观察组临床治疗有效率明显优于对照组,组间比较差异显著(P<0.05);观察组患者咳嗽、喘息、胸闷等主要临床症状缓解时间明显少于对照组,观察组患者住院时间短于对照组,组间比较差异显著(P<0.05)。结论布地奈德联合硫酸特布他林雾化吸入治疗支气管哮喘疗效确切,操作简单,对患者痛苦少,顺应性好,值得在临床上使用。

Objective To analyze clinical efficacy of Budesonide combined with Terbutaline Sulfate aerosol inhalation in the treatment of bronchial asthma. Methods 76 patients with acute onset of bronchial asthma were randomly divided into observation group and control group,with 38 cases in each group. Control group received routine treatment and observation group was inhaled with Budesonide and Terbutaline Sulfate based on routine treatment,for 7 days. Results Clinical efficiency of the observation group was significantly better than that of control group（ P〈0. 05）. The main symptoms such as cough,wheezing and chest distress were relieved earlier in the observation group compared with the control group,the hospital stay time in the observation group was significantly shorter than the control group（ P〈0. 05）. Conclusions Budesonide combined with Terbutaline Sulfate aerosol inhalation is a potential treatment of bronchial asthma due to obvious curative effect,simple operation,less pain and good compliance.